Zhitong Finance App News, Xianju Pharmaceutical (002332.SZ) issued an announcement. The company recently received the “Drug Supplement Application Approval Notice” (Notice Number: 2026B05044) for ethinyl estradiol cyproterone tablets approved and issued by the State Drug Administration. The company's ethinyl estradiol cyproterone tablets passed the consistent evaluation of the quality and efficacy of generic drugs.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.